Article Figures & Data
Tables
Patients (N=218) Age, meanyears 42 Women (%) 74 Race/ethnicity (%) White 64 African American 19 Hispanic 9 Asian 2 American Indian 1 N/A 5 Family history (%) Asthma 57 Allergies 64 Region (%) Northeast 26 South 21 Midwest 40 West 14 Total NE Region South Midwest West Allergists (no.) 4 1 0 3 0 Family physicians (no.) 5 2 1 1 1 Pulmonologist (no.) 4 0 2 1 1 Number of patients 218 56 46 86 30 Overall atopic sensitivity (%)* 68 77 61 67 67 Elevated total IgE (%) 48 59 39 47 43 Sensitivity to ≥1 specific allergen (%)† 59 68 48 57 63 Normal total IgE and ≥1 specific allergen sensitivity (%) 21 44 39 36 41 Elevated IgE by allergen sensitivity (%) Cat dander 32 43 24 27 40 Dust mite‡ 28 25 30 31 20 Common ragweed 27 43 22 21 20 Bermuda grass 22 30 20 17 20 Mold§ 17 18 13 16 23 Birch 17 25 13 12 20 Cockroach 17 25 11 14 17 Rye grass 11 12 9 11 17 * Sensitivity to one or more specific allergens and/or total serum IgE >114 kU/L,as determined by invitro serological testing.
† Determined by invitro serological testing.
‡ Dermatophagoides farinae.
§ Alternaria alternata.
- Table 3.
Percentage of Asthma Patients with Atopyand Allergen Sensitivity by Physician Specialty
Overall N =218 (%) Family Practice N = 69 (%) Allergist N = 75 (%) Pulmonology N = 74 (%) Overall atopic sensitivity* 68 70 75 61 Elevated total IgE 48 56 48 39 Sensitivity to ≥1 specific allergen† 59 61 68 47 Normal total IgE level and ≥1 specific allergen sensitivity‡ 21 9 27 22 * Sensitivity to one or more specific allergens and/or total serum IgE >114kU/L, as determined by invitro serological testing.
† Determined by invitro serological testing. χ2test of proportions used to assess differences between groups: P = .03.
‡ χ2:P = .02:
Overall (N = 218) Family Practice (N = 69) Allergy (N = 75) Pulmonology (N = 74) PValue Test results provided new information (%) 45 59 31 46 ≤.01 Would consider changes to asthma management based on test results(%) 40 55 33 34 ≤.01 If yes, type of change considered (%)* Add medication to control allergy symptoms 38 21 44 56 ≤.01 Add immunotherapy 22 16 20 32 NS† Change or discontinue asthma medications 45 39 68 32 .02 Discuss allergen avoidance 70 76 64 68 NS * N = 88 patients.
† NS, not significant at P < .05.